Studies on resistance to Marek's disease tumorigenesis: effect of immune stimulation, tumour-cell vaccines, and herpesvirus of turkeys on tumour immunity
Donahoe, J.P.; Kleven, S.H.; Eidson, C.S.
Iarc Scientific Publications 1978(24 Part 2): 1037-1041
1978
ISSN/ISBN: 0300-5038 PMID: 751899 Document Number: 128715
Document emailed within 1 workday
Related Documents
Kaleta, E.F.; Bankowski, R.A. 1972: Production of circulating and cell-bound interferon in chickens by type 1 and type 2 plaque-producing agents of the Cal-1 strain of Marek's disease herpesvirus and herpesvirus of turkeys American Journal of Veterinary Research 33(3): 573-577Okazaki, W.; Purchase, H.G.; Burmester, B.R. 1973: Vaccination against Marek's disease: possible causes of failure of herpesvirus of turkeys (strain FC126) to protect chickens against Marek's disease American Journal of Veterinary Research 34(6): 813-817
Witter, R.L.; Sharma, J.M. 1974: Transient infectivity and heterokaryon formation in hamster cell cultures inoculated with cell-associated stocks of Marek's disease virus and herpesvirus of turkeys Journal of the National Cancer Institute 53(6): 1731-1742
Kato, S.; Ikuta, K.; Hirai, K. 1983: Marek's disease virus and herpesvirus of turkeys: antigenic aspects Progress in Clinical and Biological Research 132b: 71-80
Bengelsdorff, H.J.; Keller, A.L.; Bernhardt, D. 1973: Efficiency studies on vaccines against Marek's disease, based on turkey herpes virus against the Marek disease Deutsche Tierärztliche Wochenschrift 80(18): 417-420
Bounous, G.; Sadarangani, C.; Pang, K.C.; Kongshavn, P.A. 1981: Effect of dietary amino acids on tumour growth and cell-mediated immune responses Clinical and Investigative Medicine. Medecine Clinique et Experimentale 4(2): 109-115
Ulvund, M.J. 1972: Tumour and immunity. I. General part. Theories on carcinogenesis. Immune defense mechanisms Nordisk Veterinaermedicin 24(7): 370-379
Attygalle, D.; Thavarasah, A.S. 1985: Endodermal sinus tumour of the ovary--a rare malignant germ cell tumour Ceylon Medical Journal 30(3): 111-116
Lüthje, P.; Nurmi-Lüthje, I. 2006: Tenosynovial juxta-articular giant-cell tumour of the knee--an unusual location of the tumour Acta Orthopaedica Belgica 72(6): 772-774
Schmidt, W.; Schneeweiss, U.; Fabricius, E.M. 1982: The tumour-tetanus phenomenon as a basis for computation of cell kinetic parameters of tumour growth Archiv für Geschwulstforschung 52(1): 29-40
Ray, P.K.; De, B.K.; Guha, S.; Saha, S.; Raychaudhuri, S. 1980: Facilitation and/or inhibition of growth of sarcoma-180 ascites tumour by BCG: effects of BCG on tumour cell membrane Indian Journal of Experimental Biology 18(2): 123-128
Browne, W.L.; Wilson, W.R.; Baguley, B.C.; Ching, L.M. 1998: Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid Anticancer Research 18(6a): 4409-4413
Calnek, B.W.; Carlisle, J.C.; Fabricant, J.; Murthy, K.K.; Schat, K.A. 1979: Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus American Journal of Veterinary Research 40(4): 541-548
Tonkin, K.S.; Rustin, G.J.; Wignall, B.; Paradinas, F.; Bennett, M. 1989: Successful treatment of patients in whom germ cell tumour masses enlarged on chemotherapy while their serum tumour markers decreased European Journal of Cancer and Clinical Oncology 25(12): 1739-1743
Papla, B.; Malinowski, E. 1992: Granular cell tumour (Abrikossoff tumour) of the bronchus Patologia Polska 43(1): 35-36
Batra, B.K.; Raveendran, P.; Menon, I.R. 1975: Mechanism of tumour regression by tumour cell extract Indian Journal of Medical Research 63(1): 31-35
Spencer, J.L.; Robertson, A. 1975: Influence of vaccination with avirulent herpesvirus on subsequent infection of chickens with virulent Marek's disease herpesvirus American Journal of Veterinary Research 36(8): 1235-1239
Bendre, A.R.; Gangal, S.G. 1978: Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. I. Adaptation of the virus to mouse tumour cells as a pre-requisit for adjuvanticity Indian Journal of Cancer 15(4): 1-8
Zola, H. 1974: Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen Clinical and Experimental Immunology 16(3): 469-479
Blaxland, J.D.; Macleod, A.J.; Hall, T. 1975: Trials with Marek's disease vaccines prepared from a turkey herpes virus and an attenuated Marek's disease virus Veterinary Record 97(3): 50-52